Activation of NF-кB is required for PDGF-B chain to transform NIH3T3 cells

Experimental Cell Research

Volumn 274, Issue 1, 2002, Pages 157-167

  Shimamura, Takeshi ^a   Hsu, Tin Chen ^b   Colburn, Nancy H ^b   Bejcek, Bruce E ^a  

^a WESTERN MICHIGAN UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLATELET DERIVED GROWTH FACTOR B; I KAPPA B ALPHA; NONSTEROID ANTIINFLAMMATORY AGENT; SALICYLIC ACID; SYNAPTOTAGMIN;

ANIMAL; ARTICLE; CELL STRAIN 3T3; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENETICS; METABOLISM; MOUSE; MUTATION; PHYSIOLOGY; SECOND MESSENGER; ANIMAL CELL; BLAST TRANSFORMATION; CONTROLLED STUDY; DNA BINDING; FIBROBLAST; GENE EXPRESSION; GENE SEQUENCE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION;

3T3 CELLS; ANIMALS; ASPIRIN; CELL TRANSFORMATION, NEOPLASTIC; I-KAPPA B PROTEINS; MICE; MUTATION; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-SIS; SECOND MESSENGER SYSTEMS;

EID: 0036024621     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2001.5449     Document Type: Article

References (66)

1. Production of PDGF-like growth factor by breast cancer cell lines
2. Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines
3. Differential expression of platelet-derived growth factor receptors in human malignant glioma cell lines
4. Platelet-derived growth factor-B increases colon cancer cell growth in vivo by a paracrine effect
5. Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops
6. Dominant negative mutant of the platelet derived growth factor reverts the transformed phenotype of human astrocytoma cells
7. Inhibition of glioma cell growth by a truncated platelet-derived growth factor-b receptor
8. Activated platelet-derived growth factor autocrine pathway drives the transformed phenotype of a human glioblastoma cell line
9. Binding of different dimeric forms of PDGF to human fibroblasts: Evidence for two separate receptor types
10. PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor
11. PDGF-D, a new protease-activated growth factor
12. PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor
13. Polypeptide growth factors: Roles in normal and abnormal cell growth
14. Mechanism of action and in vivo role of platelet-derived growth factor
15. Tyr-716 in the platelet-derived growth factor b-receptor kinase insert is involved in GRB2 binding and ras activation
16. Grb7 is a downstream signaling component of platelet-derived growth factor a and b receptors
17. The SH2 and SH3 domain-containing Nck protein is oncogenic and a common target for phosphorylation by different surface receptors
18. Phosphorylation sites in the PDGF receptor with different specificities for binding GAP and PI3 kinase in vivo
19. A phosphotidylinositol-3 kinase binds to platelet-derived growth factor receptors through a specific receptor sequence containing phosphotyrosine
20. cDNA cloning of a novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF β-receptor
21. Association between the PDGF receptor and members of the src family of tyrosine kinases
22. Identification of two juxtamembrane autophosphorylation sites in the PDGF b-receptor; involvement in the interaction with Src family tyrosine kinases
23. The 64-kDa protein that associates with the platelet-derived growth factor receptor b subunit via Tyr-1009 is the SH2-containing phosphotyrosine phosphatase Syp
24. Identification of two C-terminal autophosphorylation sites in the PDGF b-receptor: Involvement in the interaction with phospholipase C-g
25. Platelet-derived growth factor-dependent cellular transformation requires either phospholipase Cgamma or phosphatidylinositol 3 kinase
26. Expression of an ATP Binding Mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells
27. Induction of NF-kappa B-like activity by platelet-derived growth factor in mouse fibroblasts
28. NF-κB is a target of AKT in anti-apoptotic PDGF signaling
29. Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation
30. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN
31. A requirement for NF-κB activation in Bcr-Abl-mediated transformation
32. The inducible trnascription activator NF-κB: Regulation by distinct protein subunits
33. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding
34. Mechanistic aspects of NF-κB regulation: The emerging role of phosphorylation and proteolysis
35. In vivo control of NF-κB activation by IκBa
36. Nuclear factor-kappaB activation in human monocytes stimulated with lipopolysaccharide is inhibited by fibroblast conditioned medium and exogenous PGE2
37. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
38. Inhibition of NF-kB by sodium salicylate and aspirin
39. Regulation of platelet-derived growth factor isoform-mediated expression of prostaglandin G/H synthase in mesangial cells
40. Nucleotide sequence of transforming human c-sis cDNA clones with homology to platelet-derived growth factor
41. Failure of the splicing variant p65 delta of the NF-kappa B subunit p65 to transform fibroblasts
42. An intact PDGF signaling pathway is required for efficient growth transformation of mouse C127 cells by the bovine papillomavirus E5 protein
43. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
44. Use of fluorescently labeled DNA and a scanner for electrophoretic mobility shift assays
45. Selective inhibition of TNF-alpha induced cell adhesion molecule gene expression by tanapox virus
46. Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma
47. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases
48. Role of Val509 in time-dependent inhibition of human prostaglandin H synthase-2 cyclooxygenase activity by isoform-selective agents
49. Role of stimulation of arachidonic acid release in the proliferative response of 3T3 mouse fibroblasts to platelet-derived growth factor
50. Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein
51. Bovine papillomavirus oncoprotein E5 induces the NF kappa B activation through superoxide radicals
52. Selective inhibition of prostaglandin endoperoxide synthase-1 (cyclooxygenase-1) by valerylsalicylic acid
53. Altered sensitivity of aspirin-acetylated prostaglandin G/H synthase-2 to inhibition by nonsteroidal anti-inflammatory drugs
54. Isolation and covalent structure of the aspirin-modified, active-site region of prostaglandin synthetase
55. Inhibition of DNA synthesis by aspirin in Swiss 3T3 fibroblasts
56. The anti-inflammtory agents aspirin and salicylate inhibit the activity of IkBkinase-b
57. Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation
58. NF-κB controls growth and differentiation through transcriptional regualtion of cyclin D1
59. NF-κB function in growth control: Regulation of cyclin D1 expression and G0/G1-to-S-phase transition
60. Inhibition of nuclear factor-kappaB activity is involved in E1A-mediated sensitization of radiation-induced apoptosis
61. E1A inhibition of radiation-induced NF-kappaB activity through suppression of IKK activity and IkappaB degradation, independent of Akt activation
62. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase
63. Inhibition of ultraviolet B-induced activator protein-1 (AP-1) activity by aspirin in AP-1-luciferase transgenic mice
64. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response
65. Analysis of a transformed cell line using antisense c-fos RNA
66. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes